# Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels

> **NCT00575627** · PHASE4 · UNKNOWN · sponsor: **University of Turin, Italy** · enrollment: 150 (estimated)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Peg-Interferon alpha2a plus Ribavirin

## Key facts

- **NCT ID:** NCT00575627
- **Lead sponsor:** University of Turin, Italy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-09
- **Primary completion:** 2009-09
- **Final completion:** 2010-09
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2008-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00575627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00575627, "Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00575627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*